Moteur de recherche d’entreprises européennes

Financement de l’UE (2 999 949 €) : Vers l’élimination de la carence en iode et des maladies thyroïdiennes évitables en Europe Hor05/05/2015 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Vers l’élimination de la carence en iode et des maladies thyroïdiennes évitables en Europe

Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single most important, preventable cause of brain damage. European ID is due to significant heterogeneity in prevention and monitoring programs, leading to inappropriate interventions, increased disease burden, health inequities and increased health care costs. Up to 360 Million European citizens are exposed to ID disorders. An effective European monitoring program is a crucial step towards eradication of ID disorders with significant benefits for European citizens and the sustainability of health care systems. The effects of ID in total cause tremendous, preventable costs in health care systems of affected regions. The overall aim of EUthyroid is to evaluate ID prevention and monitoring programs in 24 European countries, to initiate capacity building for harmonized European ID prevention and monitoring programs, and to disseminate project outcomes for supporting measures on national and EU level in order to eradicate ID disorders in Europe. The project will position itself as international hub of current national initiatives in the attempt to coordinate and support existing national activities. EUthyroid will generate the first harmonized data set of ID resulting in the first valid map of iodine status in Europe. With a dedicated dissemination program about the unfavorable health outcomes of ID, EUthyroid will pave the way for a harmonized EU-wide regulation of iodination, a common approach to iodine and outcome monitoring and establish recommendations for scientists on how to monitor IDD prevention programs. The project aims to make Europe a benchmark for ID disorder prevention worldwide.


Biolution GmbH 376 276 €
Centre FOR Regional Policy Research AND Cooperation Studiorum Zdruzenje 20 178 €
Centre Hospitalier Universitaire de Toulouse 11 270,00 €
DEBRECENI EGYETEM 11 276,25 €
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH 0,00 €
Endokrinologicky Ustav 20 178 €
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM 178 340 €
Fundacion Privada Instituto de Salud Global Barcelona 89 608 €
Havforskningsinstituttet 31 506 €
Institut de Investigacio en Ciencies de La Salut Germans Trias i Pujol 20 165 €
Iodine Global Network 13 973,58 €
KLINICKI BOLNICKI CENTAR SESTRE MILOSRDNICE USTANOVA 11 125,00 €
Landspitali University Hospital 11 276,25 €
Latvijas Universitate 109 408 €
Ministerio da Defesa Nacional 20 178 €
OÜ ENDOKRINOLOOGIAKESKUS 11 270,00 €
Panepistimio Patron 73 805 €
Region Hovedstaden 272 964 €
Sofia University ST Kliment Ohridski 21 125 €
TERVEYDEN JA HYVINVOINNIN LAITOS 416 624 €
THE HEBREW UNIVERSITY OF JERUSALEM 8 000,00 €
The Queen's University of Belfast 20 178 €
Umit Tirol - Private Universitat FUR Gesundheitswissenschaften UND Technologie GmbH 398 812 €
Universita Di Pisa 11 270,00 €
UNIVERSITATSMEDIZIN GREIFSWALD KöR 572 602 €
Universite Libre de Bruxelles 11 692,50 €
University of Surrey 185 338 €
Univerzitetni Klinicni Center Ljubljana 19 875,00 €
Uniwersytet Jagiellonski 22 493 €
Uppsala Universitet 11 270,00 €
Vastra Gotalandsregionen 17 875,00 €

https://cordis.europa.eu/project/id/634453

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.